N/A N=3,074 Low vs. Standard Dose CT for Appendicitis Trial
Appendicitis
Primary: Negative Appendectomy Rate — 22; 16; 21; 16 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=39 Sunitinib in Refractory Adrenocortical Carcinoma
Adrenocortical Carcinoma
Primary: Assessment of Clinical Benefit Due to Treatment With Sunitinib — 5 Participants
N/A N=885 Rosuvastatin Adherence App Study in China
Dyslipidemia · Hyperlipidemia
Primary: Duration of Treatment — 156.7; 146.0 days — p=0.0019
N/A N=120 Optimal Inspiratory Pressure for Facemask Pressure-controlled Ventilation in Children
Child · Anesthesia
Primary: Inspiratory Pressure That Cause Gastric Insufflation — 13; 13 cmH2O
Phase 2 N=50 Efficacy and Safety of Org 25969 Administered After Zemuron® (MK-8616-042)
Neuromuscular Blockade
Primary: Time From Start of Administration of MK-8616 to Recovery T4/T1 Ratio to 0.9 — 44.18; 19.08; 5.38; 3.32 Minutes
N/A N=109 Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic
Aging
Primary: Number of Participants Who Experienced Falls — 22; 35 Participants
N/A N=51 Target Engagement for Oxytocin: Dose Ranging Study
Schizophrenia Spectrum
Primary: Mu Suppression on EEG — -0.0907; -0.0632; -0.0542; -0.1153 log10 transformed ratio (Hz)
N/A N=44 Effect of Weight Loss on Prostate Cancer Pathology
Obesity · Prostate Cancer
Primary: Apoptotic Index of the Highest Gleason Grade Malignant Epithelium in the Radical Prostatectomy Specimen Obtained After 8-weeks of the Dietary Intervention — 6.9; 5.0…
N/A N=54 Novel Device for Rapid Fluid Administration
Device Related Sepsis
Primary: Successful Administration of 60 mL/kg — 14; 18; 16 Participants
Phase 4 N=812 Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment
Infections, Streptococcal
Primary: Number of Subjects With Antibody Concentrations Against Vaccine Pneumococcal Serotypes Greater Than or Equal to (≥) the Cut-off — 144; 155; 160; 52 Participants
N/A N=94 A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters
Anemia · Diabetes · Heart Disease
Primary: Comparison of the TensorTip Accuracy Against Hospital Periodical Readings. — 0.6; 7.9; 7.5; 2.33 percentage of error
Phase 2 N=152 A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)
Neuralgia, Postherpetic
Primary: Percentage Change in Average Pain Intensity Score From Baseline to the Last Week of the 4-week Treatment Period — -26.16; -26.11; -27.36 percentage of change — p==0.965
N/A N=21 Airway Inflammation in Congenital Diaphragmatic Hernia Patients
Congenital Diaphragmatic Hernia
Primary: Number of Participants With Elevated Sputum Eosinophils — 0 participants
Phase 3 N=300 Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes
Influenza
Primary: Number of Subjects Who Were Seroprotected for Haemagglutination Inhibition (HI) Antibodies Against the Flu A/California/7/2009 (H1N1) Virus Strain — 74; 64; 69; 63…
Phase 1 N=61 BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumour
Neoplasms
Primary: Maximum Tolerated Dose — 0; 0; 0; 0 Units on a scale